Pfizer sees US antibiotic supply running out as shortage worsens
A rise in respiratory infections in the fall of last year is to blame for the present constraints in US antibiotic supplies.
By Ike Swetlitz, Bloomberg
Pfizer Inc. will run out of several doses of penicillin, which treats syphilis, strep throat, and other infections, later this year as shortages ripple across the US’s antibiotic supply.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Pfizer’s RSV shot wins US approval following GSK’s to market
For subscribers
